⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABSI News
Absci Corporation Common Stock
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
globenewswire.com
ABSI
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
prnewswire.com
AZN
HYFT
ABSI
NVDA
CERT
The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel
prnewswire.com
GOOGL
IONQ
AZN
ARQQ
QBTS
ABSI
NVDA
IBM
RGTI
CERT
Form 8-K
sec.gov
ABSI
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
globenewswire.com
ABSI
Form 8-K
sec.gov
ABSI
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
globenewswire.com
ABSI
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
prnewswire.com
HYFT
SDGR
RXRX
ABSI
CERT
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
businesswire.com
HYFT
ABSI
Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
RAPT
SANG
INCY
ABBV
ARCT
AMGN
CHKP
PFE
LLY
SCLX
SNY
UCB
BIIB
NVS
VTRS
BMY
ABSI
ALEC
GSK
IONS
CLNN
ANNX
MED
GAM
VRTX
EXC
BLRX